Login to Your Account

Berna Biotech Paying EUR279M In Cash, Shares For Rhein Biotech

By Cormac Sheridan

Wednesday, May 29, 2002
Switzerland's Berna Biotech Ltd. is acquiring Rhein Biotech NV, of the Netherlands, in a combined cash and shares deal valued at EUR279 million (US$257 million). The transaction would create a pan-European vaccines powerhouse that aims to achieve revenues of EUR300 million by 2005. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription